SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    V. López-Miranda, M. L. Soto-Montenegro, J. A. Uranga-Ocio, G. Vera, E. Herradón, C. González, C. Blas, M. Martínez-Villaluenga, A. E. López-Pérez, M. Desco, R. Abalo, Effects of chronic dietary exposure to monosodium glutamate on feeding behavior, adiposity, gastrointestinal motility, and cardiovascular function in healthy adult rats, Neurogastroenterology & Motility, 2015, 27, 9
  2. 2
    Gema Vera, Ana Esther López-Pérez, María Martínez-Villaluenga, Pablo Antonio Cabezos, Raquel Abalo, X-ray analysis of the effect of the 5-HT3 receptor antagonist granisetron on gastrointestinal motility in rats repeatedly treated with the antitumoral drug cisplatin, Experimental Brain Research, 2014, 232, 8, 2601

    CrossRef

  3. 3
    R. Abalo, P. A. Cabezos, G. Vera, A. E. López-Pérez, M. I. Martín, Cannabinoids may worsen gastric dysmotility induced by chronic cisplatin in the rat, Neurogastroenterology & Motility, 2013, 25, 5
  4. 4
    Gema Vera, Pablo Antonio Cabezos, María Isabel Martín, Raquel Abalo, Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy, Pharmacology Biochemistry and Behavior, 2013, 105, 205

    CrossRef

  5. 5
    Elżbieta Radziszewska, Ewa Bojanowska, Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2, Medical Science Monitor Basic Research, 2013, 19, 6

    CrossRef

  6. 6
    Gema Vera, Visitación López-Miranda, Esperanza Herradón, María Isabel Martín, Raquel Abalo, Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes, Pharmacology Biochemistry and Behavior, 2012, 102, 2, 335

    CrossRef

  7. 7
    Raquel Abalo, Gema Vera, Ana Esther López-Pérez, María Martínez-Villaluenga, María Isabel Martín-Fontelles, The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility, Pharmacology, 2012, 90, 1-2, 1

    CrossRef

  8. 8
    R. Abalo, P. A. Cabezos, G. Vera, V. López-miranda, E. Herradón, M. I. Martín-fontelles, Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors, Neurogastroenterology & Motility, 2011, 23, 5
  9. You have free access to this content9
    V. Di Marzo, F. Piscitelli, Gut feelings about the endocannabinoid system, Neurogastroenterology & Motility, 2011, 23, 5
  10. 10
    Angelo A. Izzo, Keith A. Sharkey, Cannabinoids and the gut: New developments and emerging concepts, Pharmacology & Therapeutics, 2010, 126, 1, 21

    CrossRef

  11. 11
    P. A. Cabezos, G. Vera, M. I. Martín-fontelles, R. Fernández-pujol, R. Abalo, Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica, Neurogastroenterology & Motility, 2010, 22, 7
  12. You have free access to this content12
    Y.-y. Li, Y.-n. Li, J.-b. Ni, C.-j. Chen, S. Lv, S.-y. Chai, R.-h. Wu, B. Yüce, M. Storr, Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus, Neurogastroenterology & Motility, 2010, 22, 3
  13. You have free access to this content13
    R. Abalo, P. A. Cabezos, G. Vera, R. Fernández-pujol, M. I. Martín, The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat, Neurogastroenterology & Motility, 2010, 22, 6